Literature DB >> 10848222

Is there a role for the immune system in glaucomatous optic neuropathy?

M B Wax1.   

Abstract

Glaucoma and immunity are not traditionally perceived as being causally related. Recently, however, compelling observations have provided insight into a potential role for the immune system in the development of glaucomatous optic neuropathy. In this article, it is proposed that the role of the immune system in glaucoma is two-fold. In some patients, there is evidence that an autoimmune mechanism may be responsible for eliciting damage to the optic nerve, resulting in glaucomatous injury. Autoimmune damage to the optic nerve may occur directly by autoantibodies, or indirectly by way of a "mimicked" autoimmune response to a sensitizing antigen which, in turn, injuries retinal ganglion cells. We suggest that autoimmune-mediated glaucoma injury occurs most often, but not exclusively, in patients in whom the intraocular pressure has never been found to be elevated. A second role of the immune system in glaucoma is likely one of surveillance, in which signal pathways of the immune system regulate cell death in response to conditions that stress retinal neurons in glaucoma. These might include mechanical stress from high intraocular pressure, ischemia, excessive excitatory amino acids, or toxic products resulting from excessive nitric oxide synthase production in either neurons or glial fibers that surround the optic nerve as it exits the eye. In these cases, we propose that the immune system acts as an "arbiter" to help determine whether a neuronal cell will ultimately survive, or succumb to, those stressors that are perceived as injurious. It is conceivable that such surveillance and cell death regulation by the immune system is important in determining the fate of retinal neurons in both the more common "high-pressure" forms of glaucoma, such as primary open-angle glaucoma, and in cases in which the intraocular pressure appears within normal range.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848222     DOI: 10.1097/00055735-200004000-00014

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  15 in total

1.  Risk factors for primary open-angle glaucoma in South Korea: the Namil study.

Authors:  Martha Kim; Tae-Woo Kim; Ki Ho Park; Joon Mo Kim
Journal:  Jpn J Ophthalmol       Date:  2012-06-05       Impact factor: 2.447

2.  Coincidence of normal tension glaucoma, progressive sensorineural hearing loss, and elevated antiphosphatidylserine antibodies.

Authors:  S Kremmer; E Kreuzfelder; E Bachor; K Jahnke; J M Selbach; S Seidahmadi
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

Review 3.  Mechanosensitivity and the eye: cells coping with the pressure.

Authors:  J C H Tan; F B Kalapesi; M T Coroneo
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

4.  Association of tumor necrosis factor alpha gene polymorphism G-308A with pseudoexfoliative glaucoma in the Pakistani population.

Authors:  Muhammad Imran Khan; Shazia Micheal; Noreen Rana; Farah Akhtar; Anneke I den Hollander; Asifa Ahmed; Raheel Qamar
Journal:  Mol Vis       Date:  2009-12-22       Impact factor: 2.367

5.  Molecular biomarkers in glaucoma.

Authors:  Sanjoy K Bhattacharya; Richard K Lee; Franz H Grus
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

Review 6.  Research progress of stem cells on glaucomatous optic nerve injury.

Authors:  Ya-Sha Zhou; Jian Xu; Jun Peng; Ping Li; Xiao-Juan Wen; Yue Liu; Ke-Zhu Chen; Jia-Qi Liu; Ying Wang; Qing-Hua Peng
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

7.  Transporter associated with antigen processing gene 1 codon 333 and codon 637 polymorphisms are associated with primary open-angle glaucoma.

Authors:  Hui-Ju Lin; Chang Hai Tsai; Fuu-Jen Tsai; Wen-Chi Chen; Huey-Yi Chen; Seng-Sheen Fan
Journal:  Mol Diagn       Date:  2004

8.  Effect of Qingguang'an II on expressions of OX42 protein and IL-1β mRNA of retinal microglia cells of rats with chronic high intraocular pressure.

Authors:  Ya-Sha Zhou; Jian Xu; Jun Peng; Yue Liu; Gen-Yan Qin; Yi-Jing Yang; Qing-Hua Peng; Han-Yu Tan
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

Review 9.  Friend or foe? Resolving the impact of glial responses in glaucoma.

Authors:  Elaine C Johnson; John C Morrison
Journal:  J Glaucoma       Date:  2009 Jun-Jul       Impact factor: 2.503

10.  Serum and antibodies of glaucoma patients lead to changes in the proteome, especially cell regulatory proteins, in retinal cells.

Authors:  Katharina Bell; Sebastian Funke; Norbert Pfeiffer; Franz H Grus
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.